Description

The TORCH panel is a group of tests used to screen for several infections that can potentially affect a developing fetus during pregnancy. The acronym “TORCH” stands for:

• T: Toxoplasmosis
• O: Other infections (such as syphilis, varicella-zoster virus, parvovirus B19)
• R: Rubella
• C: Cytomegalovirus (CMV)
• H: Herpes simplex virus (HSV)

The TORCH panel, when testing for IgM antibodies, specifically aims to detect recent or acute infections. IgM antibodies are typically produced by the immune system in response to a recent infection. Therefore, the presence of IgM antibodies against any of the pathogens in the TORCH panel suggests recent exposure to the respective infectious agent.

In the context of pregnancy, detection of IgM antibodies against these pathogens can raise concerns about potential maternal-fetal transmission and adverse effects on the developing fetus. However, it’s important to note that the presence of IgM antibodies alone may not definitively confirm active infection, as false-positive results can occur. Confirmation of infection and assessment of fetal risk often require further diagnostic testing, including additional serological tests, molecular assays, and imaging studies.

Monitoring IgM antibody levels alongside clinical symptoms, medical history, and other laboratory findings can aid in the diagnosis and management of maternal infections during pregnancy, helping to minimize the risk of adverse outcomes for both the mother and the fetus.